Glenmark Life Sciences Limited
NSE:GLS.NS
1096.1 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 5,068.79 | 5,886.16 | 5,365.97 | 5,728.04 | 5,953.63 | 5,784.5 | 6,213.2 | 5,407.31 | 5,092.99 | 4,898.7 | 5,140.57 | 5,224.99 | 5,617.61 | 5,248.97 | 4,671.63 | 5,002.29 | 5,208.05 | 3,969.68 |
| Kosten van de omzet
| 2,251.96 | 3,590.2 | 2,386.99 | 2,421.92 | 2,730.8 | 2,480.39 | 2,803.78 | 2,648.33 | 2,399.77 | 2,289 | 2,551.25 | 2,571.72 | 2,712.17 | 2,593.73 | 1,924.7 | 2,436.15 | 2,939.75 | 1,754.37 |
| Brutowinst
| 2,816.83 | 2,295.96 | 2,978.98 | 3,306.12 | 3,222.83 | 3,304.11 | 3,409.42 | 2,758.98 | 2,693.22 | 2,609.7 | 2,589.32 | 2,653.27 | 2,905.44 | 2,655.24 | 2,746.93 | 2,566.14 | 2,268.3 | 2,215.31 |
| Brutowinstmarge
| 0.556 | 0.39 | 0.555 | 0.577 | 0.541 | 0.571 | 0.549 | 0.51 | 0.529 | 0.533 | 0.504 | 0.508 | 0.517 | 0.506 | 0.588 | 0.513 | 0.436 | 0.558 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 184 | 0 | 0 | 651.77 | 167.6 | 168.6 | 0 | 571.96 | 153.9 | 181.4 | 0 | 101.62 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 816.91 | 0 | 0 | 0 | 393.03 | 0 | 0 | 0 | 375.05 | 0 | 0 | 0 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 90.07 | 0 | 0 | 0 | 54.96 | 0 | 0 | 0 | 9.98 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 848.85 | 844.98 | 841.96 | 686.03 | 884.85 | 481.32 | 906.98 | 651.41 | 614.54 | 404.56 | 447.99 | 441.31 | 485.67 | 681.34 | 385.03 | 376.37 | 424.84 | 315.2 |
| Overige kosten
| 1,624.17 | 54.93 | 31.31 | 16.91 | 53.69 | 18.51 | 28.36 | 66.08 | 100.2 | 94.93 | -92.9 | 35.34 | 20.89 | 39.86 | -0.89 | 3.72 | 0.12 | 0 |
| Bedrijfskosten
| 1,624.17 | 844.98 | 1,709.87 | 1,712.33 | 1,683.28 | 1,498.62 | 1,460.29 | 1,412.05 | 1,356.18 | 1,240.81 | 1,255.32 | 1,290.02 | 1,328.72 | 1,139.95 | 1,091.91 | 1,101.46 | 1,082.61 | 902.61 |
| Bedrijfsresultaat
| 1,192.66 | 1,450.98 | 1,300.42 | 1,610.7 | 1,593.24 | 1,805.49 | 1,977.49 | 1,413.01 | 1,437.24 | 1,368.89 | 1,334 | 1,363.25 | 1,576.72 | 1,555.15 | 1,618 | 1,468.4 | 1,185.81 | 1,295.4 |
| Bedrijfsresultaat ratio
| 0.235 | 0.247 | 0.242 | 0.281 | 0.268 | 0.312 | 0.318 | 0.261 | 0.282 | 0.279 | 0.26 | 0.261 | 0.281 | 0.296 | 0.346 | 0.294 | 0.228 | 0.326 |
| Totaal overige inkomsten en kosten netto
| 81.9 | 51.4 | -3.64 | -3.87 | -3.99 | 14.55 | -1.19 | -1.6 | -1.33 | 93.58 | 42.27 | 34.73 | -51.37 | -205.5 | -211.78 | -216.5 | -219.04 | -210.85 |
| Inkomen voor belasting
| 1,274.56 | 1,502.38 | 1,296.78 | 1,606.83 | 1,589.25 | 1,820.04 | 1,976.3 | 1,411.41 | 1,435.91 | 1,462.47 | 1,376.27 | 1,397.98 | 1,525.35 | 1,349.65 | 1,406.22 | 1,251.9 | 966.77 | 1,084.55 |
| Inkomen voor belasting ratio
| 0.251 | 0.255 | 0.242 | 0.281 | 0.267 | 0.315 | 0.318 | 0.261 | 0.282 | 0.299 | 0.268 | 0.268 | 0.272 | 0.257 | 0.301 | 0.25 | 0.186 | 0.273 |
| Belastingkosten
| 321.4 | 387.55 | 317.42 | 419.18 | 401.88 | 465.54 | 512.73 | 361.48 | 367.13 | 375.14 | 387.3 | 360.85 | 373.34 | 340.52 | 359.38 | 318.29 | 242.07 | 273.89 |
| Nettowinst
| 953.16 | 1,114.83 | 979.36 | 1,187.65 | 1,187.37 | 1,354.5 | 1,463.57 | 1,049.93 | 1,068.78 | 1,087.33 | 988.97 | 1,037.13 | 1,152.01 | 1,009.13 | 1,046.84 | 933.61 | 724.7 | 810.66 |
| Nettowinstmarge
| 0.188 | 0.189 | 0.183 | 0.207 | 0.199 | 0.234 | 0.236 | 0.194 | 0.21 | 0.222 | 0.192 | 0.198 | 0.205 | 0.192 | 0.224 | 0.187 | 0.139 | 0.204 |
| WPA (Winst Per Aandeel)
| 7.78 | 9.1 | 7.99 | 9.69 | 9.69 | 11.05 | 11.94 | 8.57 | 8.72 | 8.87 | 8.08 | 8.65 | 9.83 | 8.24 | 8.54 | 7.62 | 5.91 | 7.52 |
| Verwaterde WPA
| 7.75 | 9.08 | 7.99 | 9.67 | 9.69 | 11.05 | 11.94 | 8.57 | 8.72 | 8.87 | 8.08 | 8.65 | 9.82 | 8.24 | 8.54 | 7.62 | 5.91 | 7.52 |
| EBITDA
| 1,428.92 | 1,594.85 | 1,445.76 | 1,742.47 | 1,724.53 | 1,950.12 | 2,092.66 | 1,520.64 | 1,536.59 | 1,562.61 | 1,473.06 | 1,495.98 | 1,694.26 | 1,644.34 | 1,702.26 | 1,552 | 1,269.3 | 1,366.613 |
| EBITDA ratio
| 0.282 | 0.271 | 0.269 | 0.304 | 0.29 | 0.337 | 0.337 | 0.281 | 0.302 | 0.319 | 0.287 | 0.286 | 0.302 | 0.313 | 0.364 | 0.31 | 0.244 | 0.344 |